Sagimet Biosciences
SGMT
SGMT
63 hedge funds and large institutions have $54.4M invested in Sagimet Biosciences in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $71.6M → $54.4M (-$17.1M)
60% less call options, than puts
Call options by funds: $206K | Put options by funds: $515K
66% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 29
Holders
63
Holding in Top 10
3
Calls
$206K
Puts
$515K
Top Buyers
| 1 | +$730K | |
| 2 | +$304K | |
| 3 | +$283K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$277K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$258K |
Top Sellers
| 1 | -$2.48M | |
| 2 | -$1.71M | |
| 3 | -$1.06M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$770K |
| 5 |
Jane Street
New York
|
-$519K |